Caitlin Ditchfield

Ms. Caitlin Ditchfield


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 September 2025 in Osteoarthritis and Cartilage
Verified
Journal Article
Open access
SWSusanne Wijesinghe
Susanne Wijesinghe
MMMichael MacLeod
Michael MacLeod
ENEllie Northall
Ellie Northall
CDCaitlin Ditchfield
Caitlin Ditchfield
TNTom Nicholson
Tom Nicholson
SJSimon W Jones
Simon W Jones
To investigate the inflammatory profiles of adipose tissues from patients with osteoarthritis (OA), comparing the joint-associated adipose tissues (infrapatellar fat pad (IFP) and sub-synovial (SSAT)) with subcutaneous adipose tissue (SCAT), and to explore adipose-joint cell crosstalk. RNA sequencing was performed on autologous IFP, SSAT, and SCAT from six patients. The adipose tissue secretome was profiled using targeted proteomics. Primary joint cells (synovial fibroblasts, osteoblasts, and chondrocytes) were treated with adipose-conditioned media for 24 h, followed by RNA sequencing (N=6 per treatment). Key findings were validated using qPCR, ELISA, and recombinant protein treatments. IFP and SSAT exhibited distinct transcriptomic profiles, with 649 and 1263 differentially expressed genes (DEGs), respectively (FDR<0.1). Both IFP and SSAT showed enrichment in inflammation-related pathways, with IFP linked to innate immunity and neuroinflammation, whilst SSAT was associated with metabolism of cholesterol (p<0.05). Proteomic analysis identified 33 elevated biomarkers secreted by IFP and SSAT (p<0.05). Treatment with adipose conditioned media revealed adipose-derived signals modulated joint cell behaviour. Upstream regulator analysis identified common inflammatory and metabolic regulators across adipose conditioned media treated cells, 12 of which were detected in IFP and SSAT secretome. Further validation confirmed that transcriptional signatures identified in joint cells were driven by these shared regulators. Our findings demonstrate that joint adipose tissues contribute to inflammatory and metabolic dysfunction in OA joints. These interactions offer insight into disease pathophysiology and may help identify candidate therapeutic targets, although further in vivo studies are needed to confirm their functional relevance.

6 June 2025 in Biomolecules
Verified
Journal Article
Open access
PDF file
CDCaitlin Ditchfield
Caitlin Ditchfield
Joshua PriceJoshua Price
Joshua Price
EDEdward T Davis
Edward T Davis
SJSimon W Jones
Simon W Jones
Synovial inflammation is recognised as a pathological driver of osteoarthritis (OA), a degenerative joint disease involving cartilage degradation and joint pain. Since extracellular vesicles (EVs) have emerged as key mediators of cellular cross-talk, this study characterised synovial fluid EVs (SFEVs) in OA patients with varying disease severity and determined their functional effects on OA articular chondrocytes. Synovial fluid and articular cartilage were collected from patients undergoing knee surgery. SFEVs were isolated via ultracentrifugation and characterised by nanoparticle tracking analysis, ExoView, and Luminex analysis of protein cargo. Patients were stratified into mild/moderate- and severe-OA groups based on Oxford Knee Score and EQ5D. Chondrocytes were treated with SFEVs, and transcriptomic and secretome responses were analysed using RNA sequencing, Luminex, and ELISA. SFEVs from patients with severe OA were more abundant, smaller and exhibited increased tetraspanin expression. Synovial fluid and SFEVs induced distinct transcriptomic changes in chondrocytes. SFEVs from patients with severe OA promoted a pro-inflammatory and catabolic chondrocyte phenotype, with upregulation of CRTAC1, COL6A3, TNC, and CXCL5, greater secretion of IL-6, MMP1, MMP3 and MMP13, and pro-nociceptive mediators (NGF and Substance P). These findings suggest that SFEVs may contribute to OA progression by exacerbating cartilage damage and promoting pain sensitisation.

25 March 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
CDCaitlin Ditchfield
Caitlin Ditchfield
Joshua PriceJoshua Price
Joshua Price
EDEdward T Davis
Edward T Davis
SJSimon W Jones
Simon W Jones
Synovial inflammation is recognised as a pathological driver of osteoarthritis (OA), a degenerative joint disease involving cartilage degradation and joint pain. Since extracellular vesicles (EVs) have emerged as key mediators of cellular cross-talk, this study characterised synovial fluid EVs (SFEVs) in OA patients with varying disease severity, and determined their functional effects on OA articular chondrocytes. Synovial fluid and articular cartilage were collected from patients undergoing knee surgery. SFEVs were isolated via ultracentrifugation and characterised by nanoparticle tracking analysis, ExoView and Luminex analysis of protein cargo. Patients were stratified into mild/moderate and severe OA groups based on Oxford Knee Score and EQ5D. Chondrocytes were treated with SFEVs, and transcriptomic and secretome responses were analysed using RNA sequencing, Luminex, and ELISA. SFEVs from severe OA patients were more abundant, smaller and exhibited increased tetraspanin expression. Synovial fluid and SFEVs induced distinct transcriptomic changes in chondrocytes. SFEVs from severe OA patients promoted a pro-inflammatory and catabolic chondrocyte phenotype, with upregulation of CRTAC1, COL6A3, TNC, and CXCL5, and greater secretion of IL-6, MMP1, MMP3 and MMP13, and pro-nociceptive mediators (NGF and Substance P). These findings suggest that SFEVs may contribute to OA progression by exacerbating cartilage damage and promoting pain sensitisation.